** Morgan Stanley raises price target for Hipages Group Holdings to A$1.40 from A$1.05, keeps "equal-weight" rating
** Brokerage raises EBITDA estimates for the technology co by 6%, 8% and 9% for FY25, FY26 and FY27, respectively
** Says FY24 EBITDA of A$16.4 mln ($11.09 mln) was 6% above MS estimate and revenue of A$75.8 mln was 1% ahead of MS estimate
** "FY24 result was solid, small beat, with a positive outlook for FY25" - Morgan Stanley
** Hipages Group posted its FY results on Aug 22
** Stock had risen 61.3% this year to A$1.29, as of last close
($1 = 1.4782 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.